Hear from a panel of pioneering European healthcare professionals and a patient receiving long-acting ART as they share the latest data and recommendations and discuss their experiences, practical insights, and recommendations for implementing long-acting ART into practice.
I serve a population of migrant PWH in Belgium who I believe would benefit from long-acting ART. Do you have patients who could use long-acting ART who have not yet been included in this strategy?
Read about my experience with long-acting injectable antiretroviral therapy over the past 8 years.
Community administration is a key way to make long-acting injectable antiretroviral therapy sustainable for clinics.
Learn about the steps that clinics should take to optimally implement long-acting injectable ART for people with HIV based on examples from my clinic.
Review downloadable slides summarizing the latest data and recommendations for the implementation of long-acting ART into practice.
In this podcast, Stephane De Wit, MD, PhD, discusses the importance and the challenges of targeting migrant populations for long-acting antiretroviral therapy in Europe—and specifically in Belgium.
In this podcast, Laurence Slama, MD, PhD, discusses the logistics of allowing patients to seek a nurse in their community to administer their long-acting injectable ART after receiving the first few doses in a clinical setting.
In this podcast, Eric Florence, MD, PhD, discusses the steps that clinics should take to optimally implement long-acting injectable ART for people with HIV based on examples from his own clinic in Belgium.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.